Nasdaq Lmat News Today

Shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT – Get Free Report) hit a new 52-week high during trading on Monday after StockNews.com upgraded the stock from a hold rating to a buy rating. The stock traded as high as $75.99 and last traded at $75.71, with a volume of 62552 shares changing hands. The stock had […]

LeMaitre Vascular (NASDAQ:LMAT – Get Free Report) had its target price upped by analysts at Barrington Research from $69.00 to $79.00 in a note issued to investors on Friday, Benzinga reports. The brokerage presently has an “outperform” rating on the medical instruments supplier’s stock. Barrington Research’s price target would indicate a potential upside of 6.44% […]

LeMaitre Vascular (NASDAQ:LMAT – Get Free Report) had its target price hoisted by equities researchers at Barrington Research from $69.00 to $79.00 in a research note issued on Friday, Benzinga reports. The firm currently has an “outperform” rating on the medical instruments supplier’s stock. Barrington Research’s price objective indicates a potential upside of 6.44% from […]

LeMaitre Vascular (NASDAQ:LMAT – Get Free Report) had its price objective upped by research analysts at JMP Securities from $72.00 to $77.00 in a research note issued on Friday, Benzinga reports. The brokerage currently has a “market outperform” rating on the medical instruments supplier’s stock. JMP Securities’ target price indicates a potential upside of 3.75% […]

LeMaitre Vascular (NASDAQ:LMAT – Get Free Report) released its quarterly earnings data on Thursday. The medical instruments supplier reported $0.44 earnings per share for the quarter, topping analysts’ consensus estimates of $0.39 by $0.05, Briefing.com reports. LeMaitre Vascular had a net margin of 15.56% and a return on equity of 10.57%. The business had revenue […]

Zurcher Kantonalbank Zurich Cantonalbank raised its holdings in shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT – Free Report) by 251.6% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 10,875 shares of the medical instruments supplier’s stock after purchasing an additional 7,782 […]

LeMaitre Vascular (NASDAQ:LMAT – Get Free Report) will be posting its quarterly earnings results after the market closes on Thursday, May 2nd. Analysts expect LeMaitre Vascular to post earnings of $0.39 per share for the quarter. Investors that wish to register for the company’s conference call can do so using this link. LeMaitre Vascular (NASDAQ:LMAT […]

Linden Thomas Advisory Services LLC grew its stake in shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT – Free Report) by 2.9% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The fund owned 29,996 shares of the medical instruments supplier’s stock after buying an additional 839 shares during the […]

BURLINGTON, Mass., April 19, 2024 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its first quarter 2024...

LeMaitre Vascular (NASDAQ:LMAT – Get Free Report) and PolyPid (NASDAQ:PYPD – Get Free Report) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, institutional ownership, dividends, risk, valuation, profitability and analyst recommendations. Valuation & Earnings This table compares LeMaitre Vascular […]